Dynamic changes in mitogen-activated protein kinase (MAPK) activities in the corpus luteum of the bonnet monkey (Macaca radiata) during development, induced luteolysis, and simulated early pregnancy: A role for p38 MAPK in the regulation of luteal function

Endocrinology

Volumn 147, Issue 4, 2006, Pages 2018-2027

  Yadav, V K ^a   Medhamurthy, R ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CETRORELIX; CHORIONIC GONADOTROPIN; DNA FRAGMENT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORPUS LUTEUM; ENZYME ACTIVITY; FIRST TRIMESTER PREGNANCY; LUTEOLYSIS; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; APOPTOSIS; CASPASES; CORPUS LUTEUM; FEMALE; GONADOTROPIN-RELEASING HORMONE; IMIDAZOLES; MACACA RADIATA; MAP KINASE KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PREGNANCY; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES;

EID: 33645524139     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-1372     Document Type: Article

References (50)

1. Zeleznik AJ, Benyo DF 1994 Control of follicular development, corpus luteum function and the recognition of pregnancy in higher primates. In: Knobil E, Neill JD, eds. The physiology of reproduction. New York: Raven Press; 751-782
2. Niswender GD, Juengel JL, Silva PJ, Rollyson MK, McIntush EW 2000 Mechanisms controlling the function and life span of the corpus luteum. Physiol Rev 80:1-29
3. Hutchison JS, Nelson PB, Zeleznik AJ 1986 Effects of different gonadotropin pulse frequencies on corpus luteum function during the menstrual cycle of rhesus monkeys. Endocrinology 119:1964-1971
4. Duncan WC, McNeilly AS, Fraser HM, Illingworth PJ 1996 Luteinizing hormone receptor in the human corpus luteum: lack of down-regulation during maternal recognition of pregnancy. Hum Reprod 11:2291-2297
5. Zeleznik AJ 1998 In vivo responses of the primate corpus luteum to luteinizing hormone and chorionic gonadotropin. Proc Natl Acad Sci USA 95:11002-11007
6. Ottobre JS, Nixon WE, Stouffer RL 1984 Induction of relaxin secretion in rhesus monkeys by human chorionic gonadotropin: dependence on the age of the corpus luteum of the menstrual cycle. Biol Reprod 31:1000-1006
7. Neill JD, Knobil E 1972 On the nature of the initial luteotropic stimulus of pregnancy in the Rhesus monkey. Endocrinology 90:34-38
8. Ottobre JS, Stouffer RL 1984 Persistent versus transient stimulation of the macaque corpus luteum during prolonged exposure to human chorionic gonadotropin: a function of age of the corpus luteum. Endocrinology 114:2175-2182
9. Richards JS 2001 New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells. Mol Endocrinol 15:209-218
10. Eyster KM, Ottobre JS, Stouffer RL 1985 Adenylate cyclase in the corpus luteum of the rhesus monkey. III. Changes in basal and gonadotropin-sensitive activities during the luteal phase of the menstrual cycle. Endocrinology 117:1571-1577
11. Benyo DF, Zeleznik AJ 1997 Cyclic adenosine monophosphate signaling in the primate corpus luteum: maintenance of protein kinase A activity throughout the luteal phase of the menstrual cycle. Endocrinology 138:3452-3458
12. Niswender GD 2002 Molecular control of luteal secretion of progesterone. Reproduction 123:333-339
13. Sugino N, Kashida S, Takiguchi S, Karube A, Kato H 2000 Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy. J Clin Endocrinol Metab 85:3919-3924
14. Kohen P, Castro O, Palomino A, Munoz A, Christenson LK, Sierralta W, Carvallo P, Strauss 3rd JF, Devoto L 2003 The steroidogenic response and corpus luteum expression of the steroidogenic acute regulatory protein after human chorionic gonadotropin administration at different times in the human luteal phase. J Clin Endocrinol Metab 88:3421-3430
15. Yadav VK, Muraly P, Medhamurthy R 2004 Identification of novel genes regulated by LH in the primate corpus luteum: insight into their regulation during the late luteal phase. Mol Hum Reprod 10:629-639
16. Xu J, Stouffer RL, Searles RP, Hennebold JD 2005 Discovery of LH-regulated genes in the primate corpus luteum. Mol Hum Reprod 11:151-159
17. Johnson GL, Lapadat R 2002 Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911-1912
18. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH 2001 Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001 22:153-183
19. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME 1999 Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286:1358-1362
20. Dewi DA, Abayasekara DR, Wheeler-Jones CP 2002 Requirement for ERK1/2 activation in the regulation of progesterone production in human granulosa-lutein cells is stimulus specific. Endocrinology 143:877-888
21. Maizels ET, Mukherjee A, Sithanandam G, Peters CA, Cottom J, Mayo KE, Hunzicker-Dunn M 2001 Developmental regulation of mitogen-activated protein kinase-activated kinases-2 and -3 (MAPKAPK-2/-3) in vivo during corpus luteum formation in the rat. Mol Endocrinol 15:716-733
22. Yadav VK, Sudhagar RR, Medhamurthy R 2002 Apoptosis during spontaneous and prostaglandin F(2α)-induced luteal regression in the buffalo cow (Bubalus bubalis): involvement of mitogen-activated protein kinases. Biol Reprod 67:752-759
23. Srinath BR 1979 Husbandry and breeding of bonnet monkeys (Macaca radiata). In: Anand Kumar TC, ed. Nonhuman primate models for the study of human reproduction. Basel: S. Karger; 17-22
24. Stocco DM 2001 Tracking the role of a star in the sky of the new millennium. Mol Endocrinol 15:1245-1254
25. Peluffo MC, Young KA, Stouffer RL, Dynamic expression of caspases' protein levels and activity, but not mRNA, in the primate corpus luteum during the menstrual cycle. Program of the 36th Annual Meeting of the Society for the Study of Reproduction, Cincinnati, OH, 2003, p 81 (Abstract)
26. Carambula SF, Matikainen T, Lynch MP, Flavell RA, Goncalves PB, Tilly JL, Rueda BR 2002 Caspase-3 is a pivotal mediator of apoptosis during regression of the ovarian corpus luteum. Endocrinology 143:1495-1501
27. Yadav VK, Lakshmi G, Medhamurthy R 2005 Prostaglandin F2α-mediated activation of apoptotic signaling cascades in the corpus luteum during apoptosis: involvement of caspase activated DNase. J Biol Chem 280:10357-10367
28. Shikone T, Yamoto M, Kokawa K, Yamashita K, Nishimori K, Nakano R 1996 Apoptosis of human corpora lutea during cyclic luteal regression and early pregnancy. J Clin Endocrinol Metab 81:2376-2380
29. 5-4 isomerase messenger ribonucleic acids in the primate corpus luteum. Endocrinology 131:2065-2070
30. Duffy DM, Stewart DR, Stouffer RL 1999 Titrating luteinizing hormone replacement to sustain the structure and function of the corpus luteum after gonadotropin-releasing hormone antagonist treatment in rhesus monkeys. J Clin Endocrinol Metab 84:342-349
31. Fraser HM, Lunn SF, Harrison DJ, Kerr JB 1999 Luteal regression in the primate: different forms of cell death during natural and gonadotropin-releasing hormone antagonist or prostaglandin analogue-induced luteolysis. Biol Reprod 61:1468-1479
32. Duijkers IJ, Klipping C, Willemsen WN, Krone D, Schneider E, Niebch G, Hermann R 1998 Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers. Hum Reprod 13:2392-2398
33. Zheng RM, Zou CJ, Zhu SG 2004 p38 MAPK mediates cardiovascular and behavioral responses induced by central IL-1β and footshock in conscious rats. Acta Pharmacol Sin 25:266-270
34. Sanada S, Kitakaze M, Papst PJ, Asanuma H, Node K, Takashima S, Asakura M, Ogita H, Liao Y, Sakata Y, Ogai A, Fukushima T, Yamada J, Shinozaki Y, Kuzuya T, Mori H, Terada N, Hori M 2001 Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase. Circulation 104:705-710
35. Ward KW, Prokscht JW, Azzaranot LM, Mumawa JA, Roethke TJ, Stelman GJ, Walsh MJ, Zeigler KS, McSurdy-Freed JE, Kehlert JR, Chokshi J, Levy MA, Smith BR 2001 Preclinical pharmacokinetics of SB-203580, a potent inhibitor of p38 mitogen-activated protein kinase. Xenobiotica 31:783-797
36. Uma J, Muraly P, Verma-Kumar S, Medhamurthy R 2003 Determination of onset of apoptosis in granulosa cells of the preovulatory follicles in the bonnet monkey (Macaca radiata): correlation with mitogen-activated protein kinase activities. Biol Reprod 69:1379-1387
37. Selvaraj N, Medhamurthy R, Ramachandra SG, Sairam MR, Moudgal NR 1996 Assessment of luteal rescue and desensitization of macaque corpus luteum brought about by human chorionic gonadotrophin and de-glycosylated human chorionic gonadotrophin treatment. J Biosci 21:497-510
38. Adams SM, Murphy CR 2001 A successful pregnancy following SEM fine tuning of hormonal priming. BMC Pregnancy Childbirth 1:3
39. Maher P 1999 p38 Mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation. J Biol Chem 274:17491-17498
40. Mackay K, Mochly-Rosen D 1999 An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia. J Biol Chem 274:6272-6279
41. Medhamurthy R, Gupta P, Characterization of cAMP/PKA/CREB pathway in the primate corpus luteum: expression of cAMP-responsive genes under different functional status. 74th Annual Meeting of the Society of Biological Chemists, Lucknow, India, 2005, p 24 (Abstract 67)
42. Svechnikov K, Stocco DM, Soder O 2003 Interleukin-1α stimulates steroidogenic acute regulatory protein expression via p38 MAP kinase in immature rat Leydig cells. J Mol Endocrinol 30:59-67
43. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC 1995 SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364:229-233
44. Clerk A, Sugden PH 1998 The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs). FEBS Lett 426:93-96
45. Cameron MR, Foster JS, Bukovsky A, Wimalasena J 1996 Activation of mitogen-activated protein kinases by gonadotropins and cyclic adenosine 5′-monophosphates in porcine granulosa cells. Biol Reprod 55:111-119
46. Das S, Maizels ET, DeManno D, St Clair E, Adams SA, Hunzicker-Dunn M 1996 A stimulatory role of cyclic adenosine 3′,5′-monophosphate in follicle-stimulating hormone-activated mitogen-activated protein kinase signaling pathway in rat ovarian granulosa cells. Endocrinology 137:967-974
47. Cowley S, Paterson H, Kemp P, Marshall CJ 1994 Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852
48. Salvador LM, Maizels E, Hales DB, Miyamoto E, Yamamoto H, Hunzicker-Dunn M 2002 Acute signaling by the LH receptor is independent of protein kinase C activation. Endocrinology 143:2986-2994
49. Taylor CC 2000 Platelet-derived growth factor activates porcine thecal cell phosphatidylinositol-3-kinase-Akt/PKB and ras-extracellular signal regulated kinase-1/2 kinase signaling pathways via the platelet-derived growth factor-β receptor Endocrinology 141:1545-1553
50. Seger R, Hanoch T, Rosenberg R, Dantes A, Merz WE, Strauss 3rd JF, Amsterdam A 2001 The ERK signaling cascade inhibits gonadotropin-stimulated steroidogenesis. J Biol Chem 276:13957-13964